The European medicines regulatory network needs to up its game in the area of data analysis and digital health so that it can keep up with new developments in technology and “get at least on a par with the pharmaceutical industry, if not ahead,” says Thomas Senderovitz, director general of the Danish medicines agency.
“Regulators can’t be a bottleneck